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Abstract 
The protein sequence of the hyoscyamine 6β-hydroxylase gene from Hyoscyamusniger was analysed in silico for its potential of 
heterologous expression. Therefore different parameters determining the proteins properties and structure in prokaryotic or 
eukaryotic protein expression systems were taken into account. In silico prediction of co- and post-translational modifications 
revealed 25 putative glycosylation sites, one of which reported to be a co-factor stabilizing residue in 2-oxoglutarate dependent 
dioxygenases. Potential protein solubility and degradation (PEST) motifs were also evaluated. Together with the calculated 
physico-chemical properties the results indicated reasonable solubility but potential instability of the protein in Escherichia coli 
and Saccharomyces cerevisiae. Further a synthetic h6h-gene was introduced into the prokaryotic or eukaryotic hostsEscherichia 
coli and Saccharomyces cerevisiae to determine protein expression. The protein could be expressed in both organisms, though 
stability was confirmed to be an issue. 
© 2014 The Authors. Published by Elsevier B.V. 
Peer-review under responsibility of the School of Pharmacy, Bandung Institute of Technology. 
Keywords: Tropan-Alkaloids; Hyoscyamine; Scopolamine; H6H; heterologous expression; disulfide bridges; glycosylation; PEST motifs 
1. Introduction 
Tropane alkaloids are a class of plant secondary metabolites that exist in Solanaceae and Convolvulaceae. The 
biosynthetic pathway has many branch points, besides infamous end- and side-products like nicotine and cocaine, 
one product of particular industrial relevance is atropine1, 2. Thistropane alkaloid,which is the racemic mixture of d- 
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and l-hyoscyamine, and its downstream metabolic product scopolamine are widely used as pharmaceuticals due to 
their anticholinergic activity3. Scopolamine is the more valuable alkaloid, with a ten times higher commercial 
demand than that of hyoscyamine because of the fewer side effects and higher physiological activity3. Hyoscyamine 
is the more abundant alkaloid produced in plants3. As scopolamine is the compound of greater useability in 
agriculturally bred Solanaceae for drug industry, the enzyme limiting this step is point of major interest3. Hashimoto 
et al., first identified a 2-oxoglutarate-dependent dioxygenase from Hyoscyamusniger that hydroxylateshyoscyamine 
at the 6β-position and further epoxidates it to scopolamine: Hyoscyamine 6β-hydroxylase (H6H), a 2-oxoglutarate-
dependent dioxygenase4. It catalyses two reactions: The first is the 6β-hydroxylation of the l-hyoscyamin’stropane 
ring to 6β-hydroxyhyoscyamine (anisodamine) (Fig. 1)5. In a second step an intramolecular epoxide formation takes 
place via the removal of the 6β-hydrogen resulting in the formation of scopolamine (Fig. 1)5. Although both 
reactions are catalysed by the same enzyme (hyoscyamine 6β-hydroxylase), different EC numbers are applied for 
the first (EC 1.14.11.11) and the second (EC 1.14.11.14) step. The epoxidase activity is relatively weak and 
represents only 1 – 10% of the hydroxylase activity and therefore the limiting step6. Hyoscyamine 6β-hydroxylases 
belong to the family of oxidoreductases, specifically to those acting on paired donors, with O2 as oxidant and 
incorporation or reduction of oxygen7. The enzyme incorporates one atom of molecular oxygen into the tropane 
moiety of hyoscyamine at C-6, the second oxygen atom is incorporated in 2-oxoglutarate, decarboxylating the α-
keto acid to succinate and CO28. H6H is highly stereo-selective as it only oxidizes the l-isomer of atropine8. Two 
cofactors are taking part in the reaction: Fe2+ and ascorbate8. The epoxidation requires the same co-factors as the 
hydroxylation6. Due to these co-factors H6H is prone to inhibition by divalent cations and oxo-acids6. 
 
Fig. 1.Reaction mechanism of l-hyoscyamine to scopolamine with anisodamine(7β-hydroxyhyoscyamine) as intermediate and the cofactors Fe2+ 
and ascorbate. The co-substrates 2-oxoglutarate and O2 are converted to the by-products succinate and CO2. 
To maximize scopolamine production, overexpression of hyoscyamine 6β-hydroxylase in plants, and microbial 
production of the recombinant enzyme in genetically modified microorganisms are possible applications of 
bioengineering and subject to current research1, 3.In order to develop a microbial production system for H6H in a 
genetically modified microorganismfor conversion of abundant hyoscyamine to scopolamine the expression host 
must be considered. Co- or post-translational modifications are essential for structure formation of the protein and 
therefore important for the activity and half-life time of the enzyme: Disulfide bonds, formed between the thiol 
groups of cystein residues, play an important role in the folding and stability of some proteins, though, due to the 
reducing environment inside cells, mostly for proteins secreted to the extracellular medium9. Most eukaryotic 
proteins do not perform their function without undergoing some ways of post-translational modification. 
Glycosylation, a common post-translational modification, plays a role in protein folding, transport and half-life10. 
Different types of glycosylation exist, N-linked and O-linked glycosylation are the most common forms10. Protein 
half-life is also affected by certain recognition sequences which are rich in proline (P), glutamic acid (E), serine (S), 
and threonine (T)11. These PEST motifs are associated with proteins that have a short intracellular half-life11. Finally 
the expression of a heterologous protein can be prone to solubility issues12. While some approaches exist to express 
and characterize different H6H genes in E. coli5, 13-16 and S. cerevisiae17, these parameters have not been taken into 
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account. This study is focused on providing support when aiming to establish a recombinant production system for 
hyoscyamine 6β-hydroxylase. 
2. Experiments 
The 344 residues amino acid sequence of H6H from H. niger used for the performed analyses were derived from 
the original publication14 and is shown below: 
          10         20         30         40         50         60 
  MATFVSNWST KSVSESFIAP LQKRAEKDVP VGNDVPIIDL QQHHHLLVQQ ITKACQDFGL 
          70         80         90        100        110        120 
  FQVINHGFPE ELMLETMEVC KEFFALPAEE KEKFKPKGEA AKFELPLEQK AKLYVEGEQL 
         130        140        150        160        170        180 
  SNEEFLYWKD TLAHGCHPLD QDLVNSWPEK PAKYREVVAK YSVEVRKLTM RMLDYICEGL 
         190        200        210        220        230        240 
  GLKLGYFDNE LSQIQMMLTN YYPPCPDPSS TLGSGGHYDG NLITLLQQDL PGLQQLIVKD 
         250        260        270        280        290        300 
  ATWIAVQPIP TAFVVNLGLT LKVITNEKFE GSIHRVVTDP TRDRVSIATL IGPDYSCTIE 
         310        320        330        340 
  PAKELLNQDN PPLYKPYSYS EFADIYLSDK SDYDSGVKPY KINV 
2.1.  In silico studies 
Glycosylation sites were predicted using the tool described by Hamby et al.10, PEST motifs were analysed using 
EMBOSS: pestfind developed by Rechsteiner et al.11, cysteines likely to be partners in cysteine bridges were 
identified using the tool described by Fariselli et al.9 andphysico-chemical properties and solubility were determined 
using ExPASyProtParam by Gasteiger et al.18 and PROSO II by Smialowski et al.12.Protein structure was also 
modelled using Phyre 219. 
2.2.  In vitro studies 
2.2.1. Strain construction 
A synthetic h6h-gene was constructed outgoing from the H6H amino acid sequence and obtained from GeneArt® 
Life Technologies™, the sequence is shown below: 
1   ATGGCCACAT TTGTCTCCAA CTGGTCCACC AAATCTGTCT CTGAATCCTT    50 
51  CATTGCCCCT TTACAAAAGA GAGCCGAAAA GGACGTTCCT GTTGGTAATG   100 
101 ACGTTCCAAT CATCGACTTA CAACAACACC ACCATTTGTT AGTACAACAA   150 
151 ATCACTAAGG CCTGCCAAGA CTTCGGTTTA TTCCAAGTCA TCAACCACGG   200 
201 TTTCCCTGAA GAATTGATGT TAGAAACAAT GGAAGTCTGT AAGGAATTTT   250 
251 TCGCCTTGCC TGCCGAAGAA AAGGAAAAAT TCAAACCAAA GGGTGAAGCT   300 
301 GCCAAATTCG AATTGCCATT AGAACAAAAG GCAAAATTGT ATGTCGAAGG   350 
351 TGAACAATTG TCCAACGAAG AATTCTTGTA TTGGAAGGAC ACCTTGGCTC   400 
401 ATGGTTGCCA CCCATTAGAC CAAGACTTGG TCAACTCTTG GCCTGAAAAA   450 
451 CCTGCCAAGT ATAGAGAAGT TGTCGCCAAA TATTCTGTAG AAGTTAGAAA   500 
501 ATTGACTATG AGAATGTTGG ACTATATCTG TGAAGGTTTG GGTTTAAAGT   550 
551 TGGGTTATTT CGATAACGAA TTGTCCCAAA TCCAAATGAT GTTAACCAAC   600 
601 TATTATCCAC CATGCCCAGA TCCATCTTCC ACTTTGGGTT CCGGTGGTCA   650 
651 CTATGACGGT AACTTGATCA CATTATTACA ACAAGACTTG CCTGGTTTAC   700 
701 AACAATTGAT CGTCAAGGAT GCCACATGGA TTGCCGTTCA ACCAATTCCA   750 
751 ACCGCTTTCG TCGTCAACTT GGGTTTAACC TTGAAAGTCA TCACAAACGA   800 
801 AAAATTTGAA GGTTCCATCC ACAGAGTTGT TACCGATCCT ACTAGAGATA   850 
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851 GAGTTTCTAT CGCCACCTTA ATCGGTCCAG ACTATTCCTG TACCATCGAA   900 
901 CCTGCTAAGG AATTGTTGAA TCAAGACAAC CCTCCTTTGT ATAAACCATA   950 
951 TTCATATTCC GAATTCGCCG ACATTTATTT GAGTGACAAA TCCGATTATG  1000 
1001ACTCCGGTGT CAAACCTTAT AAGATCAACG TC                     1032 
 
Outgoing from the commercially available plasmids pET15b (Novagen® | Merck) and pYES2/CT (Invitrogen™ | 
Life Technologies™), vectors were constructed for E. coli and S. cerevisiae respectively, by cloning the synthetic 
h6h-gene into the designated vectors restriction sites. The restriction sites were chosen in a way that for E. coli 
constructs expression H6H with N-terminal 6xHis-tag were obtained, which was located on pET15b adjacent to the 
polylinker region. Primers for amplification of the insert can be found in table 1; the restriction sites are shown in 
bold. 
Table 1. Primers for insert preparation for pET15b vector 
Primer Sequence Tm 
NdeI 6xHis forward 5'-ACGTCATATGGCCACATTTG-3' 63.64°C 
BamHI reverse 5'-CGTCTAATAAGGATCCACGT-3' 58.65°C 
For S. cerevisiae constructs with C-terminal V5-epitope, sequence located on pYES2/CT adjacent to the 
polylinker region, were produced. The h6h-sequence was preceded by a yeast consensus sequences for improved 
initiation of translation. Primers for amplification of the insert can be found in table 2; the restriction sites are shown 
in bold. 
Table 2. Primers for insert preparation for pYES2/CT vector 
Primer Sequence Tm 
HindIII forward 5'-AGTCAAGCTTAAAAAAATGGCCACATTTGTC-3' 71.6°C 
XhoI V5-His reverse 5'- CTGACTCGAGGACGTTGATCTTATAAG -3' 68.5°C 
 
Cloning was undertaken following the steps outlined in Novagen®’s pET System Manual 11th Edition20. The 
obtained constructs were transformed to the E. coli strain Rosetta-gami™ 2(DE3) obtained from Novagen® and the 
S. cerevisiae protease knock out strain YPL154c (derived from BY4742, obtained from the EUROSCARF culture 
collection) respectively. Transformations were carried out using the protocol described by Froger et al.21 and Ito et 
al.22forE. coli and S. cerevisiae respectively. 
2.2.2. Protein expression 
E. coli was cultivated on LB medium at 37°C as recommended in the Novagen® competent cells user protocol: 
Single colonies were streaked out on LB plates (containing ampicillin, chloramphenicol and tetracycline for 
selection) to provide enough inoculum for pre-cultures on liquid medium. After 16 h at 37°C the inoculum was 
transferred to 5 mL LB medium in 15 mL falcon tubes containing the respective antibiotics. The falcon tubes were 
inoculated at 37°C with continuous shaking for 24 h. By than enough cells were gained to inoculate 200 mL medium 
in 1 L baffled shake flasks. The cells were washed twice prior to inoculation. At an OD600 of 0.3 the lac operon 
induced expression by joining a 1 M filter sterilized IPTG stock solution to a final concentration of 1 mM. After 22 h 
at 30°C the cells were harvested by centrifugation at an average OD600 of 2. 
S. cerevisiae was cultivated as described inVelagapudi et al23. Single colonies were streaked out on minimal 
medium plates without uracil, to provide enough inoculum for pre-cultures on liquid medium. After 24 h at 30°C the 
inoculum was transferred to 25 mL glucose minimal medium without uracil in 250 mL shake flasks. After 
incubation for 28 h at 37°C with continuous shaking the cells were harvested in the end of the log-phase at an OD660 
of 5. The cells were washed twice and used to inoculate minimal medium without uracil (carbon source2 % 
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galactose to induce the gal promoter) to an initial OD660 of 0.5. After 23 h at 30°C an average OD660 of 9 was 
reached and the cells were harvested. 
Cells that had been harvested by centrifugation at 8,000 x g for 10 min. at 4°C were washed twice with H2O 
bidest., the wet weight of the pellet was determined and the cells were resuspended in 10 volumes of breaking buffer 
which was composed of 50 mM phosphate buffer pH 7.8 with one tablet per 10 mL Complete Mini EDTA-free 
Protease Inhibitor Cocktail (Roche). The cells were lysed using an SLM AMINCO French®Press (two passes 1,200 
PSIG, 1” diameter piston). The cell lysates were centrifuged at 25,000 x g for 10 min. at 4°C (Sorvall® RC 6™ Plus 
Superspeed-Centrifuge by Thermo Scientific) to sediment all remaining non-soluble cell fragments. 
Proteins were quantified using a Bradford protein assay24. Immobilized metal affinity chromatography (IMAC) 
was used to purify and subsequently identify the His-tagged protein from expression in E. coli by SDS-PAGE25. The 
cartridge used for IMAC was a Bio-Scale™ Mini Profinity™ IMAC (by Bio-Rad) in combination with a GradiFrac 
programmable fraction collector (Pharmacia Biotech AB). Buffer compositions were: Equilibration buffer (A): 50 
mM sodium phosphate, 300 mM sodium chloride, 20 mM imidazole; pH 7.8. Elution buffer (B): 50 mM sodium 
phosphate, 300 mM sodium chloride, 300 mM imidazole; pH 7.8.The protein was bound on the column and eluted in 
fractions for which the protein concentrations weredetermined. To visualize the proteins 10% acrylamide SDS gels 
were prepared and used in aMinigel SDS-PAGE chamber by biometra (analytic jena)as recommended in the "Lab 
FAQs" by Roche. The marker was a PageRuler™ Plus Pre-stained Protein Ladder. 
For theS. cerevisiaestrains expression was proven by immune-detection of the V5-epitope on a Western Blot25, 
26.For an immunoblotthe proteins from an SDS gel were transferred to a PVDF membrane at 100 mA for 45 –60 
min. in buffer composed of 150 mMglycin, 25 mMTris 10% MeOH at pH 8.5. The blotting chamber was a Fastblot 
Semi-Dry Electrophoretic transfer apparatus by biometra (analytic jena). The 2-step immune-detection was 
performed using the monoclonal mouse anti-V5 antibody by invitrogen™ (Life Technologies™) to manufacturer 
recommendations. 
3. Results and Discussion 
3.1. In silico studies 
3.1.1. Prediction of glycosylation sites and potential impact on enzyme activity 
Glycosylation of H6H has so far not been reported in the literature. Therefore possible glycosylation was 
determinedin silico, giving 25 glycosylation sites. The results for each amino acid residue can be found in table 6 in 
the appendix. 
It has been reported in literature that for 2-oxoglutarate dependent dioxygenasesFe2+ is weakly bound by three 
amino acid side chains that typically occur in a His1-X-Asp/Glu-Xn-His2 motif27. When utilized as a substrate, 2-
oxoglutarate chelates the Fe2+ using its C-1 carboxylate and C-2 ketone, with additional binding stabilization 
provided by the C-5 carboxylate interacting with other side chains. From this the particular residues for H6H were 
derived and can be found in table 3. 
Table 3.Putative metal ligands and 2-oxoglutarate binding residues of hyoscyamine 6β-hydroxylase27 
Ligand 1 Ligand 2 Ligand 3 2-oxoglutarate C-5 stabilization 
His 217 Asp 219 His 274 Arg 284, Ser 286 
Of the calculated glycosylation sites one is the amino acid residue 286 which also is involved in stabilizing the 
reaction co-factor 2-oxoglutarate and is therefore likely to be part of the active site. As prokaryotes like E. coli are 
not capable of glycosylation like plants, a protein expressed in E. coli would be missing glycosylation which could 
result in reduced activity. This would also explain the relatively low activities that so far have been reported for 
various heterologous expressed H6Hs5, 13-17.The eukaryote S. cerevisae is capable of glycosylation in its secretory 
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pathway so that targeting the expression of H6H there could prove worthwhile in terms of activity but might also 
help to increase solubility and therefore expression levels. 
3.1.2. Potential proteolytic cleavage sites 
Eight PEST motifs, all with a poor score, were identified in the H6H sequence. The results are depicted in table 
4, an alignment of the PEST motifs to the sequence given in Fig. 2. 
Table 4. PEST motifs in H6H amino acid sequence, all scores below -5 are rated poor 
PEST motif frame PEST score 
12 – 22 -17.4 
67 – 80 -10.35 
138 – 149 -5.09 
184 – 216 -7.37 
218 – 238 -22.02 
240 – 261 -20.78 
285 – 302 -12.24 
 
    ---------+---------+---------+---------+---------+---------+ 
   1 MATFVSNWSTKSVSESFIAPLQKRAEKDVPVGNDVPIIDLQQHHHLLVQQITKACQDFGL 60 
               OOOOOOOOOOO 
  61 FQVINHGFPEELMLETMEVCKEFFALPAEEKEKFKPKGEAAKFELPLEQKAKLYVEGEQL 120 
              OOOOOOOOOOOOOO 
121 SNEEFLYWKDTLAHGCHPLDQDLVNSWPEKPAKYREVVAKYSVEVRKLTMRMLDYICEGL 180 
                   OOOOOOOOOOOO 
 181 GLKLGYFDNELSQIQMMLTNYYPPCPDPSSTLGSGGHYDGNLITLLQQDLPGLQQLIVKD 240 
       OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO OOOOOOOOOOOOOOOOOOOOO O 
 241 ATWIAVQPIPTAFVVNLGLTLKVITNEKFEGSIHRVVTDPTRDRVSIATLIGPDYSCTIE 300 
     OOOOOOOOOOOOOOOOOOOOO                       OOOOOOOOOOOOOOOO 
 301 PAKELLNQDNPPLYKPYSYSEFADIYLSDKSDYDSGVKPYKINV 344 
     OO             OOOOOOOOOOOOOO  
 
      Symbols   PEST motifs 
      +++++++   potential 
      OOOOOOO   poor 
 
Fig. 2. Distribution of PEST motifs in H6H amino acid sequence. 
Although low in score approx. half of the H6H amino acid sequence contains motifs that render it prone for 
degradation by proteases. The computed instability index of 35.73classified the protein as stablein vitro, although the 
value is just barely below the threshold of 40. Estimated in vivo half-life times were calculated to be more than 20 
hours for the N-terminal unmodified protein inS. cerevisiaeand minimum 10 hours for the protein with the N-
terminal 6xHis-tag in Escherichia coli18. Given the faster metabolism of E. coli, protein expression might be 
obtained quicker compensating for reduced stability. 
3.1.3. Identification of potential disulfide bridges 
Six cysteins are present in the H6H amino acid sequence, of which one is likely to be a partner in a cysteine 
bridge while the others are unlikely to form a disulfide bridge (Table 5). 
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Table 5.Cysteins in H6H amino acid sequence and predicted participation in disulfide bridges 
Cysteine residue Predicted state Reliability 
CYS 55 NON-Bonding 90 % 
CYS 80 NON-Bonding 90 % 
CYS 136 NON-Bonding 90 % 
CYS 177 NON-Bonding 90 % 
CYS 205 Bonding 80 % 
CYS 297 NON-Bonding 90 % 
This indicates that disulfide bound formation is irrelevant for the structure of H6H, as a minimum of two cysteins 
are needed to form a bridge. Therefore this factor can be neglected when choosing an expression host. 
3.1.4. Physico-chemical properties and solubility 
The calculated molecular weight of H6H from H. niger is 39 kDa, the theoretical isoelectric point (pI) of the 
protein is 5.02.Cytoplasmic proteins in yeast exhibit a distinct clustering around pI 5 to 628.Recently it has been 
reported, that a high isoelectric point of the protein to be expressed heterologous diminishes the chance of expression 
(it is thought that the cytosolic accumulation of proteins with apI above a certain threshold is down-regulated)[28]. It 
has been found that cytosolically expressed proteins should therefore have pI values generally below 7 in order to 
favour expression. This is given for H6H making it favourable for expression in a yeast. 
Proteins of E. coli are typically found to have pI around 6 or 929. While no study exists that indicates a relation of 
pI to the expressability of proteins in E. coli, it might still be concluded that a protein with a pI in the common range 
for E. coli is more easily expressed due to its better solubility at isoelectric charge. This is supported by findings 
from the protein solubility evaluator12which classified the protein as soluble in E. coli with a factor of 0.79 (low to 
high from 0 to 1, solubility threshold is 0.6). 
3.1.5. Protein structure 
A three dimensional Protein Data Bank format (pdb) compliant protein structure model of the H6H was 
computed and is provided as a separate file or can be obtained upon request from the corresponding author. Fig. 3 
depicts the 2d model. 
 
Fig. 3.Modelled 2d structure of H6H. 
The structure was found to have identity with putative 2-oxoglutarate/-Fe(II) dependentoxygenase family proteins 
andoxidoreductases of the iron/ascorbate family, but also penicillin synthase-like proteins of the superfamily of 













clavaminate synthase-likes. Studying the reaction mechanism and binding sites of these could trigger modifications 
that might be used to improve the activity of H6H. For this the generated pdb file can be used to predict the change 
of the protein stability when mutating the amino acid sequence in favour of activity and / or protein stability using 
the method reported by Yin et al30.However binding sites for H6H could yet not be predicted due to insufficient 
template data. Including the motives outlined in Hausinger27could help to define these. 
3.2. In vitro studies 
3.2.1. Expression in E. coli 
The pET15b-h6h vector expression cassette was introduced into the E. coli expression hosts Rosetta gami 
2(DE3). Expression could be verified for the His-tagged construct of pET5b-h6h after partial purification of the 
protein by immobilized metal affinity chromatography. This was concluded from the SDS-PAGE of three elution 
fractions, giving a band around 40 kDa (Fig. 4).The protein was obtained after 22 h at 30°C with 1 mM IPTG on LB 
medium. In addition to the strong band at 40 kDa a fainter band at a lower mass could be seen. This indicates a 
smaller fragment of the protein, possibly due to degradation. In the SDS-PAGE of the crude protein extract (data not 
shown) the respective band however was not distinguishable from overlaying bands. This indicates that no “over-
expression” was obtained. The reason might be the codon usage as the same sequence as for S. cerevisiae was 
utilized, though Rosetta gami 2 strains provide additional tRNAs for rare codons. Protein solubility was at this 








Fig. 4.SDS-PAGE of fractions from IMAC of protein extract from E. coliRosetta gami 2(DE3) pET15b-h6h strain. 
3.2.2. Expression in S. cerevisiae 
 
The pYES2/CT-h6h constructs were used to transform the BY4742 derived S. cerevisiae strain. Expression could 
be proven by Western Blot for the constructs expressing the H6H protein fused with the V5 epitope. Expression 
conditions were 30°C, 23 h and 2% galactose on minimal medium. Besides the band at a matching mass 
ofapprox.41 kDa (corresponds to the size of H6H plus the fusion tag), bands at lower masses could also be observed 
(Fig. 5).These are most likely degradation products due to digestion of the protein by proteases. From Western Blot 
being a very sensitive analytical method it could be concluded that expression levels are comparatively low, 
noticeable from to the thin and faint bands. Addressing this by targeting the secretory pathway of S. cerevisiae to 
glycosylate the protein could provide enhanced stability of the protein as well as better solubility and therefore 
higher expression levels. 
 
 







Fig. 5. Western Blot of protein extract from four identical clones of the BY4742 derived S. cerevisiae strain carrying the pYES2/CT-h6h plasmid 
with V5-fusion tag. 
4. Conclusion 
Different protein specific parameters were determined in silico and taken into account to evaluate E. coli and 
S. cerevisiae as potential expression hosts for H6H. It was found that glycosylation is likely and could possibly also 
be crucial for the protein to develop its full activity. Further, theoretical protein stability was assessed and potential 
instability could be associated with the sequence. It could be shown in vitro that expression is possible in both hosts. 
Expression levels were found to be comparatively low and protein degradation is a major issue. This correlates with 
the findings from the theoretical analysis pointing out the challenge of heterologous expression of H6H. In future 
glycosylation could be the key to tackle this problem giving a eukaryotic expression system the favour. 
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